DocGo Inc. (NASDAQ:DCGO) Shares Bought by Barclays PLC

Barclays PLC lifted its stake in shares of DocGo Inc. (NASDAQ:DCGO) by 279.7% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 134,923 shares of the company’s stock after purchasing an additional 99,387 shares during the period. Barclays PLC’s holdings in DocGo were worth $447,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the company. Centiva Capital LP purchased a new position in DocGo in the third quarter worth approximately $43,000. Intech Investment Management LLC acquired a new stake in shares of DocGo in the 3rd quarter valued at $62,000. Victory Capital Management Inc. lifted its position in shares of DocGo by 124.0% during the 2nd quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock worth $79,000 after purchasing an additional 14,191 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of DocGo by 31.6% during the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock worth $125,000 after purchasing an additional 9,696 shares in the last quarter. Finally, SG Americas Securities LLC increased its holdings in DocGo by 97.5% in the third quarter. SG Americas Securities LLC now owns 38,147 shares of the company’s stock valued at $127,000 after buying an additional 18,835 shares during the last quarter. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Needham & Company LLC reaffirmed a “buy” rating and set a $7.00 price target on shares of DocGo in a report on Thursday. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $6.10.

Insider Activity at DocGo

In related news, General Counsel Ely D. Tendler sold 23,088 shares of the firm’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the transaction, the general counsel now owns 175,645 shares in the company, valued at $779,863.80. This trade represents a 11.62 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 2.70% of the stock is owned by corporate insiders.

DocGo Trading Down 2.3 %

Shares of NASDAQ:DCGO opened at $4.17 on Friday. The firm has a 50 day simple moving average of $4.23 and a 200-day simple moving average of $3.69. DocGo Inc. has a twelve month low of $2.75 and a twelve month high of $4.86. The company has a market capitalization of $425.55 million, a PE ratio of 14.89, a P/E/G ratio of 11.49 and a beta of 0.97.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.